Literature DB >> 28102823

Oral Immunotherapy for Food Allergy.

R A Wood1.   

Abstract

Food allergy is a potentially life-threatening condition with no approved therapies apart from avoidance and injectable epinephrine for treatment of acute allergic reactions. Oral immunotherapy (OIT) is an experimental treatment in which patients consume gradually increasing quantities of the food to which they are allergic in an attempt to induce some level of desensitization. While desensitization is possible in most patients, OIT carries significant risks for allergic reactions, and the ability to induce longer-term tolerance has not yet been established. This review focuses on selected studies of OIT for the treatment of common food allergies such as cow's milk, hen's egg, and peanut.

Entities:  

Keywords:  Cow’s milk; Desensitization; Food allergy; Hen’s egg; Immunoglobulin E (IgE); Omalizumab; Oral immunotherapy; Peanut; Skin prick test (SPT); Sustained unresponsiveness; Tolerance

Mesh:

Substances:

Year:  2017        PMID: 28102823     DOI: 10.18176/jiaci.0143

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  20 in total

1.  Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy.

Authors:  Elisa Benelli; Andrea Trombetta; Laura Badina; Stefanny Andrade; Giulia Zamagni; Antonio Prisco; Eugenio Traini; Egidio Barbi; Irene Berti
Journal:  Immun Inflamm Dis       Date:  2022-07

Review 2.  Eosinophilic esophagitis during sublingual and oral allergen immunotherapy.

Authors:  Joseph Cafone; Peter Capucilli; David A Hill; Jonathan M Spergel
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-08

Review 3.  Next-Generation Approaches for the Treatment of Food Allergy.

Authors:  Jennifer A Dantzer; Robert A Wood
Journal:  Curr Allergy Asthma Rep       Date:  2019-01-28       Impact factor: 4.806

4.  Microneedles coated with peanut allergen enable desensitization of peanut sensitized mice.

Authors:  Akhilesh Kumar Shakya; Rohan S J Ingrole; Gaurav Joshi; Md Jasim Uddin; Sara Anvari; Carla M Davis; Harvinder Singh Gill
Journal:  J Control Release       Date:  2019-10-15       Impact factor: 9.776

Review 5.  Regulatory Requirements for the Quality of Allergen Products for Allergen Immunotherapy of Food Allergy.

Authors:  Lisa Englert; Vera Mahler; Andreas Bonertz
Journal:  Curr Allergy Asthma Rep       Date:  2021-05-10       Impact factor: 4.806

6.  The effect of omalizumab treatment on severe allergic asthma and allergic comorbidities: real-life experience from the Czech Anti-IgE Registry.

Authors:  Beáta Hutyrová; Jaromír Bystroň
Journal:  Postepy Dermatol Alergol       Date:  2018-07-19       Impact factor: 1.837

7.  T-cell activation by transgenic rice seeds expressing the genetically modified Japanese cedar pollen allergens.

Authors:  Shinya Takaishi; Saburo Saito; Tomonori Endo; Daiya Asaka; Yuhya Wakasa; Hidenori Takagi; Kenjiro Ozawa; Fumio Takaiwa; Nobuyoshi Otori; Hiromi Kojima
Journal:  Immunology       Date:  2019-08-23       Impact factor: 7.397

Review 8.  Targeting the FcεRI Pathway as a Potential Strategy to Prevent Food-Induced Anaphylaxis.

Authors:  Melanie C Dispenza; Bruce S Bochner; Donald W MacGlashan
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

Review 9.  The Use of Bruton's Tyrosine Kinase Inhibitors to Treat Allergic Disorders.

Authors:  Melanie C Dispenza
Journal:  Curr Treat Options Allergy       Date:  2021-04-16

10.  Protective Effect of Glycomacropeptide on Food Allergy with Gastrointestinal Manifestations in a Rat Model through Down-Regulation of Type 2 Immune Response.

Authors:  Diana Reyes-Pavón; Daniel Cervantes-García; Luis G Bermúdez-Humarán; Laura Elena Córdova-Dávalos; Andrés Quintanar-Stephano; Mariela Jiménez; Eva Salinas
Journal:  Nutrients       Date:  2020-09-25       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.